01 Jan Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group
Posted at 00:00h
in
Authored by: Benard Antoine, van Sighem Ard, Taieb Audrey, Valadas Emilia, Ruelle Jean, Soriano Vicente, Calmy Alexandra, Balotta Claudia, Damond Florence, Brun-Vezinet Françoise, Chene Geneviève, Matheron Sophie
In: CLINICAL INFECTIOUS DISEASES 52(10), 2011, p.1257-1266
http://www.ncbi.nlm.nih.gov/pubmed/21507923